Log In
Print this Print this

SB-061, SB061

  Manage Alerts
Collapse Summary General Information
Company Symic Biomedical Inc.
DescriptionMimic of the proteoglycan aggrecan
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationOsteoarthritis
Indication DetailsTreat mild to moderate osteoarthritis (OA) of the knee; Treat osteoarthritis
Regulatory Designation
PartnerNordic Bioscience A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today